Orion Investment Company’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Orion Investment Company's BMY Position: Q2 2026 in Review
Orion Investment Company reduced its Bristol-Myers Squibb (BMY) stake by 22% in Q2 2026, selling an estimated $289K and leaving 17,512 shares worth $1.01M. The position accounts for 0.29% of the portfolio, ranked #47.
Orion Investment Company first reported a position in BMY in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.54M in Q1 2025. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Orion Investment Company held 17,512 shares of Bristol-Myers Squibb worth $1.01M as of Q2 2026.
- Orion Investment Company sold 5,041 Bristol-Myers Squibb shares in Q2 2026, an estimated $289K.
- Bristol-Myers Squibb made up 0.29% of Orion Investment Company's portfolio in Q2 2026, its #47 holding.
- Orion Investment Company first reported a position in Bristol-Myers Squibb in Q2 2024 and has held it in 9 quarters since.
- Orion Investment Company's Bristol-Myers Squibb position peaked at $1.54M in Q1 2025.
- 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Orion Investment Company's 13F filing for Q2 2026, filed 11 Aug 2026.